Pfizer Says Its Virus Vaccine Could Be Ready for October Review

Source: Aljazeera »

Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from an early-stage study.

The companies said the vaccine was well tolerated with mild to moderate fever in fewer than 20% of the participants. The companies are continuing to analyze data from the…

Leave a Reply

Your email address will not be published. Required fields are marked *